Before treatment, patients need a diagnosis confirmed by ... based on a blood test as the enrolment criterion for dementia drug trials. That could pave the way for those blood tests, which look ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...
A study has now shown that these patients do not show the ... Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19, 2024 — A recently published study ...
ScienceAlert on MSN1d
Shockingly Common Injury Linked With Increased Risk of DementiaOlder adults who experience injurious falls are more likely to develop dementia within a year of their accident compared to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
CMS will promote the approval of ZUNVEYL in China as soon as possible to bring a new drug option for the treatment of cognitive impairment in Alzheimer’s disease patients. ZUNVEYL was approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback